ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.580
+0.150 (3.39%)
Feb 13, 2026, 4:08 PM HKT
ImmuneOnco Biopharmaceuticals (Shanghai) Employees
ImmuneOnco Biopharmaceuticals (Shanghai) had 195 employees as of June 30, 2025. The number of employees increased by 39 or 25.00% since the number was reported on December 31, 2024.
Employees
195
Change
39
Growth
25.00%
Revenue / Employee
690.23K HKD
Profits / Employee
-1.70M HKD
Market Cap
1.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 195 | 39 | 25.00% |
| Dec 31, 2024 | 156 | 11 | 7.59% |
| Dec 31, 2023 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,629 |
| Frontage Holdings | 1,540 |
| Mabpharm | 383 |
| Cutia Therapeutics | 298 |
| Zhaoke Ophthalmology | 270 |
| Immunotech Biopharm | 173 |
| Antengene Corporation | 152 |
| Shanghai Bio-heart Biological Technology | 70 |